SEC 13F Intelligence

Amova Asset Management Americas, Inc. / ADPT

Amova Asset Management Americas, Inc.’s Adaptive Biotechnologies Cor Position

Does Amova Asset Management Americas, Inc. own Adaptive Biotechnologies Cor (ADPT)? Yes — 1.60M shares worth $22M (+0.31% of its 13F portfolio) as of Q1 2026, down from 1.95M shares the prior filed quarter.

Position Value
$22M
Q1 2026
Shares
1.60M
% of Portfolio
+0.31%
Quarters Held
24
currently held

Position History ADPT

Reported value by quarter
Q2 ’20: $7MQ2 ’20Q3 ’20: $8MQ4 ’20: $13MQ1 ’21: $16MQ1 ’21Q2 ’21: $71MQ3 ’21: $67MQ4 ’21: $87MQ4 ’21Q1 ’22: $57MQ2 ’22: $36MQ3 ’22: $33MQ3 ’22Q4 ’22: $41MQ1 ’23: $45MQ2 ’23: $43MQ2 ’23Q3 ’23: $36MQ4 ’23: $32MQ1 ’24: $20MQ1 ’24Q2 ’24: $25MQ3 ’24: $40MQ4 ’24: $41MQ4 ’24Q1 ’25: $45MQ2 ’25: $50MQ3 ’25: $55MQ3 ’25Q4 ’25: $32MQ1 ’26: $22Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.60M$22M+0.31%
Q4 20251.95M$32M+0.37%
Q3 20253.65M$55M+0.53%
Q2 20254.30M$50M+0.50%
Q1 20256.09M$45M+0.58%
Q4 20246.83M$41M+0.44%
Q3 20247.73M$40M+0.45%
Q2 20246.92M$25M+0.29%
Q1 20246.18M$20M+0.20%
Q4 20236.51M$32M+0.31%
Q3 20236.57M$36M+0.43%
Q2 20236.38M$43M+0.45%
Q1 20235.32M$45M+0.51%
Q4 20225.35M$41M+0.59%
Q3 20224.84M$33M+0.42%
Q2 20224.62M$36M+0.45%
Q1 20224.14M$57M+0.42%
Q4 20213.16M$87M+0.46%
Q3 20212.03M$67M+0.29%
Q2 20211.78M$71M+0.28%
Q1 2021398.8K$16M+0.08%
Q4 2020224.8K$13M+0.08%
Q3 2020190.5K$8M+0.07%
Q2 2020166.6K$7M+0.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amova Asset Management Americas, Inc.’s full portfolio or all institutional holders of ADPT.